Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci Capital

WALTHAM, Mass.--(BUSINESS WIRE)--Axial Therapeutics Inc., a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that company management will participate in a fireside chat hosted by LifeSci Capital on Tuesday, November 17, 2020 at 1:00 PM ET.

About Axial Therapeutics

Axial Therapeutics is a clinical-stage, biopharmaceutical company pioneering novel science focused on the interaction between the brain and the gut to mitigate the causes and symptoms of the central nervous system and other gut-derived diseases. The Company has built a pipeline of novel small molecules with lead programs to address the significant unmet patient needs associated with Parkinson’s Disease and Autism Spectrum Disorder.